Solactive Future Pharmaceutical Europe Index
The Solactive Future Pharmaceutical Europe Index tracks the performance of the 15 largest European pharmaceutical companies by market capitalization, weighted according to their “Innovation Value”, thereby allocating more weight to companies investing a higher percentage of their total assets in research and development.
Master Data
| ISIN: | DE000SLA5EB2 |
| Bloomberg Ticker: | SOLFUPHA Index |
| WKN: | SLA5EB |
Current Quotes
| Last quote (08 Nov 2024): | 658.91 |
| Day range: | 658.91 / 658.91 |
| Change abs./rel.: | 0.00 / 0.00% |
| Year range: | 533.32 / 697.32 |
| Name | Number of shares |
|---|---|
| ROCHE HOLDING AG | 0.290437 |
| SWEDISH ORPHAN BIOVITRUM AB | 0.632792 |
| BAYER AG | 0.589147 |
| ASTRAZENECA PLC | 0.458509 |
| SANOFI SA | 0.325401 |
| GALDERMA GROUP AG | 0.202215 |
| RECORDATI SPA | 0.665518 |
| ARGENX SE | 0.210617 |
| NOVO NORDISK A/S | 0.287769 |
| GSK PLC | 1.754027 |
| NOVARTIS AG | 0.324411 |
| MERCK KGAA | 0.100444 |
| UCB SA | 0.427833 |
| GENMAB A/S | 0.409759 |
| SANDOZ GROUP AG | 0.450667 |